
Bioorganic and Medicinal Chemistry Letters p. 875 - 880 (1999)
Update date:2022-08-05
Topics:
Nishi, Takahide
Fukazawa, Tetsuya
Ishibashi, Koki
Nakajima, Katsuyoshi
Sugioka, Yuki
Iio, Yukiko
Kurata, Hitoshi
Itoh, Kazuhiro
Mukaiyama, Osamu
Satoh, Yumiko
Yamaguchi, Takeshi
We report herein the synthesis and structure-activity relationships of a series of novel oxazolidine analogues with regards to NK1 and NK2 tachykinin receptor binding affinity. Among this series of oxazolidine analogues, some compounds exhibited excellent high binding affinities for both NK1 and NK2 receptors. In addition, we describe the inhibitory effect in vivo on SP-induced airway vascular hyperpermeability and NKA-induced bronchoconstriction in guinea pigs.
View MoreLINYI FUDE FINE CHEMICAL CO.,LTD
Contact:86-539-2361184
Address:YISHUI, LINYI,SAHNDONG,CHINA
Beijing Apis Biotechnology Co., Ltd.
Contact:86-010-67856775-8551
Address:NO.4PUHUANGYU ROAD,FENTAI DISTRICT, BEIJING, CHINA
Jinan Kaypharm Chemical Co.,Ltd
Contact:86-0531-86986780
Address:Room101,No189-2,Huayuan Road,Jinan City,Shandong Province
Jinan Decheng Hemu Medical Technology Co.,Ltd.
Contact:+86-531-68650525
Address:NO.554 Zhengfeng Road High-new Technology Development Zone
Suzhou Jingye Medicine & Chemical Co., Ltd
Contact:+86-512-66658588
Address:No. 88, Sanlian Street, Jinfeng Road, Suzhou New District, Jiangsu Province, P. R. China
Doi:10.1007/s00044-018-2249-y
(2018)Doi:10.1039/c8ob00477c
(2018)Doi:10.1139/v69-054
(1969)Doi:10.1016/S0277-5387(96)00564-5
(1997)Doi:10.1002/zaac.201000444
(2011)Doi:10.1021/jo061515x
(2007)